We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dual-Function Wound Patch Combines Infection Sensing and Treatment

By LabMedica International staff writers
Posted on 24 Mar 2026

Chronic wounds require continuous, adaptive care and place a heavy burden on health systems. More...

Clinicians need dressings that can detect early infection while providing therapy without frequent changes. Existing “smart” dressings typically monitor or medicate, but integrating both functions in one device has been challenging. Researchers have now developed a dual‑function wound patch that aims to simplify monitoring and treatment in a single, scalable platform.

Researchers at RMIT University (Melbourne, Australia) have created a hydrogel‑based smart wound dressing that embeds carbon dots, which are biocompatible carbon nanoparticles, directly into the material. The platform is designed to sense the wound state and deliver therapy using the same integrated system. The approach seeks to reduce design complexity compared with devices that rely on separate, expensive sensing components.

The dressing leverages carbon dots to image and sense changes in the wound microenvironment while acting as therapeutic artificial enzymes, or nanozymes, to counter inflammation. It changes color in response to pH shifts associated with infection, enabling readout with portable smart devices. When infection‑related signals are detected, the hydrogel automatically releases therapeutic nanozymes, and clinicians or patients can also trigger release manually by applying gentle pressure to the patch.

Initial studies were conducted at lab scale, with validation in appropriate in vivo wound models identified as a key next step. The team is seeking industry partnerships to refine the design and scale manufacturing for clinical translation. According to the researchers, the patch’s dual function could support more timely and effective intervention by enabling responsive detection and treatment in one dressing.

The work drew on RMIT’s Micro Nano Research Facility and its Microscopy and Microanalysis Facility. The study, titled “Carbon-dot nanozyme-empowered responsive hydrogels for smart wound dressing,” was published in Chemical Engineering Science. The researchers report that the streamlined design is intended to address barriers that have limited commercialization of smart wound dressings.

“Many smart wound dressings developed in research laboratories are difficult to translate into real clinical products because they rely on complex designs or expensive sensing systems,” said Dr Haiyan Li, Senior Lecturer at RMIT’s School of Engineering.  “Our approach integrates sensing and dual-mode therapeutic functions into a single dressing with a simple, streamlined design, which helps address some of the key challenges that have previously limited commercial translation.” 

“Ultimately, our goal is to translate this research into practical smart wound dressings and integrate this smart platform into a digital health ecosystem, where the data from the patch is collected, analysed, and used to drive clinical decisions to advance chronic wound management,” said Dr Lei Bao, Senior Lecturer at RMIT’s School of Engineering.

Related Links
RMIT University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers compared Huntington’s disease biomarkers in CSF and blood with clinical assessments and brain imaging to better understand changes before clinical onset (Image Credit: Adobe Stock)

Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene that progressively affects movement, cognition, behavior, and independence. Although mutation carriers can be identified... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.